Reason for joining:
The goal is to achieve a consensus on better cooperation of cleft centers in conducting research and sharing knowledge
Current research interest in relation to the COST Action:
Treatment outcomes and health related quality of life outcomes in patients with Robin Sequence.
COST Actions Outcomes:
Link to CV: CV-link
Link to institution: https://www.hetwkz.nl/nl/Ziekenhuis
Bob Logjes obtained his MD at the University Medical Center Utrecht in 2017.He is part of Dr. Corstiaan Breugem's research group in Utrecht and he conducted one year of his PhD research at the University of California San Francisco